Aortic Valve Replacement Device Market Size
The global aortic valve replacement devices market size was valued at USD 7.26 billion in 2025 and is expected to reach USD 9.24 billion by 2034, at a CAGR of 2.63% during the forecast period 2025-2034.
Aortic Valve Replacement Device Market Overview
The increasing prevalence of aortic stenosis and cardiovascular diseases (CVDs) and the rising access to healthcare facilities are contributing to the growth of the global aortic valve replacement devices market. The global increase in the elderly population and rising incidences of heart diseases have led to a surge in the demand for transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) procedures.
The technological advancements in the design of valves offer numerous advantages in terms of improved results and decreased risks associated with the procedure and quicker recovery, thus propelling the whole market. The uptick in awareness, coupled with the rising availability of patients who require complex cardiac interventions, is a few of the factors that are surging the market growth globally.
These factors lead to a significant increase in the development of aortic valve replacement devices, enabling significant improvements in valve durability and biocompatibility, as well as successful procedural outcomes. The use of AI-assisted imaging and immediate procedure monitoring has also reduced errors and improved the post-op success rate due to an increase in precision.
Get Free Sample Copy @ https://businessresearchindustry.com/free-sample-download/?report-id=5200
Given the growing preference for bioprosthetic valves over mechanical valves, we anticipate significant growth opportunities in the aortic valve replacement market. Bioprosthetic valves are mainly constructed from bovine or porcine pericardium and hence are more biocompatible and durable and, unlike mechanical valves, do not require long-term anticoagulation therapy.
Based on Leaflet, the market is segmented by bovine pericardium and porcine pericardium. Bovine pericardium caters to the largest market share owing to the fact that it has superior tensile strength and better hemodynamic performance with a lesser calcification rate as compared to porcine pericardium.
Top medical device companies mainly use bovine pericardium in their TAVR and SAVR heart valves because it lasts longer and has a lower chance of breaking down. Research shows that bovine pericardial valves have a longer durability than porcine valves and are preferred for younger and more active patients.
Although some earlier clinical trials have proven that blood-thinning medicine could improve short-term results, in most cases it is preferred to not use blood-thinning treatment, and that is why more and more of the hospitals around Europe, the U.S., and Japan are using bovine-based bioprosthetic valves to improve long-term clinical results.
US, European, and Japanese hospitals also increasingly use bovine pericardial valves in high-risk and elderly patients since they are able to provide good valve durability and do not require lifelong anticoagulation therapy. Porcine pericardial valves are currently still an alternative, but they are associated with higher calcification rates and limited durability, leading to limited market penetration.
Due to the increasing geriatric population, rising prevalence of cardiovascular disorders, and improving healthcare facilities, we expect the Asia-Pacific region to grow rapidly. With the increasing accessibility to healthcare and various initiatives from respective governments, the demand for TAVR and other minimally invasive cardiac procedures is gaining enormous momentum in countries such as China, India, Japan, and South Korea.
As an example, next-generation aortic valve replacement technology has been adopted by various hospitals in China, including Beijing Anzhen Hospital and Fuwai Hospital, resulting in significantly increased procedural volume.
BRI has comprehensively analyzed the global aortic valve replacement devices market. We have explained the driving forces, restraints, challenges, opportunities, and key trends in detail to depict an in-depth scenario of the market. Segment-wise market size and market share during the forecast period are duly addressed to portray the probable picture of this global aortic valve replacement devices industry.
The competitive landscape includes key innovators, aftermarket service providers, market giants, and niche players. We extensively study and analyze these, focusing on their strengths, weaknesses, and potential for value addition. In addition, this report covers key player profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends, and dynamics in partnerships.
List of the prominent players in the Aortic Valve Replacement Devices Market:
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- Artivion Inc.
- Anteris Technologies Ltd.
- JenaValve Technology Inc.
- CryoLife Inc.
- LifeNet Health Inc.
- Thubrikar Aortic Valve Inc.
- Colibri Heart Valve
- Meril Life Sciences Pvt Ltd
- BioTronik
- Coroneo Inc.
- Terumo Corporation
- LeMaitre Vascular
- MicroPort Scientific Corporation
- Nipro Corporation
- Shanghai Kindly Medical Instruments Co. Ltd.
- Others
Read Full Report with Table of Contents: https://businessresearchindustry.com/report/aortic-valve-replacement-devices-market/
About Us:
We at the Business Research Industry enrich the strategic market insight that we bring to our clients. We are here to increase the strategy execution and revenue growth uniformity. Offering high-level market blueprints and solutions without regular surveys is what we bring for you. We provide syndicated market studies, tailored research reports, and consultation.
From discussing investment fluctuation to grabbing hidden opportunities, we offer intense market studies covering complete analysis with relatable statistics. We ensure that we add recommendations in our final reports to make it easy for the organization to succeed.
Contact Us:
Business Research Industry
A 1401 Kakkad Lavida
Sr.No.11/8/21, Near Laxmi Mata Mandir,
Balewadi, Haveli, Pune, 411045
Phone: +91 820 819 7130